National Bank of Canada
JAZZ icon

National Bank of Canada’s Jazz Pharmaceuticals JAZZ Stock Holding History

National Bank of Canada’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$243K Sell
1,287
-37
-3% -$6.47K ﹤0.01% 1579
2025
Q4 		$225K Buy
1,324
+609
+85% +$93.4K ﹤0.01% 1567
2025
Q3 		$94K Buy
715
+286
+67% +$34.3K ﹤0.01% 1780
2025
Q2 		$45.4K Buy
429
+258
+151% +$28K ﹤0.01% 1985
2025
Q1 		$21.1K Buy
+171
New +$22.3K ﹤0.01% 2074
2024
Q3 		– Sell
-144
Closed -$15.3K – 2909
2024
Q2 		$15.3K Sell
144
-251
-64% -$27.6K ﹤0.01% 2031
2024
Q1 		$43.3K Buy
395
+20
+5% +$2.45K ﹤0.01% 1805
2023
Q4 		$47.6K Buy
375
+20
+6% +$2.5K ﹤0.01% 1779
2023
Q3 		$45.3K Sell
355
-1,468
-81% -$196K ﹤0.01% 1833
2023
Q2 		$226K Buy
1,823
+1,010
+124% +$136K ﹤0.01% 1434
2023
Q1 		$119K Sell
813
-1,878
-70% -$278K ﹤0.01% 1510
2022
Q4 		$429K Buy
2,691
+897
+50% +$131K ﹤0.01% 1299
2022
Q3 		$239K Hold
1,794
– – ﹤0.01% 1320
2022
Q2 		$280K Buy
1,794
+26
+1% +$4K ﹤0.01% 1331
2022
Q1 		$275K Buy
1,768
+1,499
+557% +$218K ﹤0.01% 1431
2021
Q4 		$35K Buy
+269
New +$35.4K ﹤0.01% 1989

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

National Bank of Canada's JAZZ Position: Q1 2026 in Review

National Bank of Canada reduced its Jazz Pharmaceuticals (JAZZ) stake by 2.8% in Q1 2026, selling an estimated $6.47K and leaving 1,287 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #1579.

National Bank of Canada first reported a position in JAZZ in Q4 2021 and has held it in 16 quarters since. The position peaked at $429K in Q4 2022. 572 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • National Bank of Canada held 1,287 shares of Jazz Pharmaceuticals worth $243K as of Q1 2026.
  • National Bank of Canada sold 37 Jazz Pharmaceuticals shares in Q1 2026, an estimated $6.47K.
  • Jazz Pharmaceuticals made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #1579 holding.
  • National Bank of Canada first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 16 quarters since.
  • National Bank of Canada's Jazz Pharmaceuticals position peaked at $429K in Q4 2022.
  • 572 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.